 | • レポートコード：TPM-BG029 • 出版社/出版日：Transparency Market Research / 2018年7月 • レポート形態：英文、PDF、254ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、バイオ医薬品発酵システムの世界市場について調べ、バイオ医薬品発酵システムの世界規模、市場動向、市場環境、製品別（上流製品、下流製品）分析、用途別（組換えタンパク質、モノクローナル抗体、抗生物質、プロバイオティクス）分析、最終用途別（バイオ医薬品企業、 医薬品製造受託機関、医薬品開発受託機関、学術研究機関、食品産業）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・バイオ医薬品発酵システムの世界市場動向 ・バイオ医薬品発酵システムの世界市場環境 ・バイオ医薬品発酵システムの世界市場規模 ・バイオ医薬品発酵システムの世界市場規模：製品別（上流製品、下流製品） ・バイオ医薬品発酵システムの世界市場規模：用途別（組換えタンパク質、モノクローナル抗体、抗生物質、プロバイオティクス） ・バイオ医薬品発酵システムの世界市場規模：最終用途別（バイオ医薬品企業、 医薬品製造受託機関、医薬品開発受託機関、学術研究機関、食品産業） ・バイオ医薬品発酵システムの世界市場：地域別市場規模・分析 ・バイオ医薬品発酵システムの北米市場規模・予測 ・バイオ医薬品発酵システムのアメリカ市場規模・予測 ・バイオ医薬品発酵システムの中南米市場規模・予測 ・バイオ医薬品発酵システムのヨーロッパ市場規模・予測 ・バイオ医薬品発酵システムのアジア市場規模・予測 ・バイオ医薬品発酵システムの日本市場規模・予測 ・バイオ医薬品発酵システムの中国市場規模・予測 ・バイオ医薬品発酵システムのインド市場規模・予測 ・バイオ医薬品発酵システムの中東市場規模・予測 ・バイオ医薬品発酵システムのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Biopharmaceutical Fermentation Systems Market: Overview
This report analyzes the global biopharmaceutical fermentation systems market in terms of its current and future scenario. Microbial cell systems have been in use for biopharmaceutical production since the introduction of recombinant insulin. Ease of gene translation and bioproduction process has contributed to the significant adoption of microbial systems in biopharmaceutical production. Rise in research and development activities, technological advancements, increase in awareness about products, and new product launches are some of the factors likely to drive the biopharmaceutical fermentation systems market in the near future.
This report on the global biopharmaceutical fermentation systems market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product, application, end-user, and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. In addition, the section comprises a competitive matrix and company profiles with a business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the biopharmaceutical fermentation systems market.
Global Biopharmaceutical Fermentation Systems Market: Key Segments
Based on product, the global biopharmaceutical fermentation systems market has been segmented into upstream products ( fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation, culture media, buffers & inducers, other upstream products) and downstream products (filtration & separation systems, chromatography, consumables & accessories, and other downstream products). In terms of application, the market has been classified into recombinant proteins, monoclonal antibodies, antibiotics, probiotics, and others. Based on end-user, the market has been segmented into biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, food industry, and others. The global biopharmaceutical fermentation systems market has been analyzed based on technology trends, expenditure on emerging technologies, and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Biopharmaceutical Fermentation Systems Market: Regional Outlook
In terms of region, the global biopharmaceutical fermentation systems market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period 2018-2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.
Companies Mentioned in Report
The report profiles major players operating in the global biopharmaceutical fermentation systems market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report are GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius StedimBiotech, Merck KGaA, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedicals, Lonza, and Becton, and Dickinson and Company.
The global biopharmaceutical fermentation systems market has been segmented as follows:
Biopharmaceutical Fermentation Systems Market, by Product
Upstream Products
Fermenters
Bioprocess Analyzers
Process Monitoring Devices
Culture & Media Preparation
Culture Media, Buffers & Inducers
Other Upstream Products
Downstream Products
Filtration & Separation Systems
Chromatography
Consumables & Accessories
Other Downstream Products
Biopharmaceutical Fermentation Systems Market, by Application
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics
Others (Amino Acids, Enzymes, Polysaccharides, etc.)
Biopharmaceutical Fermentation Systems Market, by End-user
Biopharmaceutical Companies
Contract Manufacturing Organizations
Contract Research Organizations
Academic Research Institutes
Food Industry
Others
Biopharmaceutical Fermentation Systems Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Biopharmaceutical Fermentation Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Key Trends
4.4. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Price Comparison Analysis (2017)
5.1.1. By Product
5.1.2. By Region
5.2. Key Potential Customers
5.2.1. Key Potential Customers by Region
5.3. Key Distributor Analysis
5.4. Bioprocess Analyzers Segment Analysis & Overview
5.5.Technological Advancements
5.6.Key Mergers & Acquisitions
6. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2016–2026
6.3.1. Upstream Products
6.3.1.1. Bioreactors/Fermenters
6.3.1.2. Bioprocess Analyzers
6.3.1.3. Process Monitoring Systems
6.3.1.4. Media & Culture Preparation
6.3.1.5. Culture Media, Buffers & Inducers
6.3.1.6. Other Upstream Products
6.3.2. Downstream Products
6.3.2.1. Filtration & Separation
6.3.2.2. Chromatography
6.3.2.3. Consumables & Accessories
6.3.2.4. Other Downstream Products
6.4. Market Attractiveness, by Product
7. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2016–2026
7.3.1. Antibiotics
7.3.2. Monoclonal Antibodies
7.3.3. Recombinant Proteins
7.3.4. Probiotics
7.3.5. Others
7.4. Market Attractiveness, by Application
8. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by End-users
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-User, 2016–2026
8.3.1. Biopharmaceutical Companies
8.3.2. Contract Manufacturing Organizations
8.3.3. Contract Research Organizations
8.3.4. Academic Research Institutes
8.3.5. Food Industry
8.3.6. Others
8.4. Market Attractiveness, by End-User
9. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Biopharmaceutical Fermentation Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016–2026
10.2.1. Upstream Products
10.2.1.1. Bioreactors/Fermenters
10.2.1.2. Bioprocess Analyzers
10.2.1.3. Process Monitoring Systems
10.2.1.4. Media & Culture Preparation
10.2.1.5. Culture Media, Buffers & Inducers
10.2.1.6. Other Upstream Products
10.2.2. Downstream Products
10.2.2.1. Filtration & Separation
10.2.2.2. Chromatography
10.2.2.3. Consumables & Accessories
10.2.2.4. Other Downstream Products
10.3. Market Value Forecast, by Application, 2016–2026
10.3.1. Antibiotics
10.3.2. Monoclonal Antibodies
10.3.3. Recombinant Proteins
10.3.4. Probiotics
10.3.5. Others
10.4. Market Value Forecast, by End-users, 2016–2026
10.4.1. Biopharmaceutical Companies
10.4.2. Contract Manufacturing Organizations
10.4.3. Contract Research Organizations
10.4.4. Academic Research Institutes
10.4.5. Food Industry
10.4.6. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Biopharmaceutical Fermentation Systems Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product, 2016–2026
11.2.1. Upstream Products
11.2.1.1. Bioreactors Fermenters
11.2.1.2. Bioprocess Analyzers
11.2.1.3. Process Monitoring Systems
11.2.1.4. Media & Culture Preparation
11.2.1.5. Culture Media, Buffers & Inducers
11.2.1.6. Other Upstream Products
11.2.2. Downstream Products
11.2.2.1. Filtration & Separation
11.2.2.2. Chromatography
11.2.2.3. Consumables & Accessories
11.2.2.4. Other Downstream Products
11.3.Market Value Forecast, by Application, 2016–2026
11.3.1. Antibiotics
11.3.2. Monoclonal Antibodies
11.3.3. Recombinant Proteins
11.3.4. Probiotics
11.3.5. Others
11.4.Market Value Forecast, by End-users, 2016–2026
11.4.1. Biopharmaceutical Companies
11.4.2. Contract Manufacturing Organizations
11.4.3. Contract Research Organizations
11.4.4. Academic Research Institutes
11.4.5. Food Industry
11.4.6. Others
11.5.Market Value Forecast, by Country, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-users
11.6.4. By Country
12. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product, 2016–2026
12.2.1. Upstream Products
12.2.1.1. Bioreactors/Fermenters
12.2.1.2. Bioprocess Analyzers
12.2.1.3. Process Monitoring Systems
12.2.1.4. Media & Culture Preparation
12.2.1.5. Culture Media, Buffers & Inducers
12.2.1.6. Other Upstream Products
12.2.2. Downstream Products
12.2.2.1. Filtration & Separation
12.2.2.2. Chromatography
12.2.2.3. Consumables & Accessories
12.2.2.4. Other Downstream Products
12.3.Market Value Forecast, by Application, 2016–2026
12.3.1. Antibiotics
12.3.2. Monoclonal Antibodies
12.3.3. Recombinant Proteins
12.3.4. Probiotics
12.3.5. Others
12.4.Market Value Forecast, by End-users, 2016–2026
12.4.1. Biopharmaceutical Companies
12.4.2. Contract Manufacturing Organizations
12.4.3. Contract Research Organizations
12.4.4. Academic Research Institutes
12.4.5. Food Industry
12.4.6. Others
12.5.Market Value Forecast, by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-users
12.6.4. By Country
13. Latin America Biopharmaceutical Fermentation Systems Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product, 2016–2026
13.2.1. Upstream Products
13.2.1.1. Bioreactors/Fermenters
13.2.1.2. Bioprocess Analyzers
13.2.1.3. Process Monitoring Systems
13.2.1.4. Media & Culture Preparation
13.2.1.5. Culture Media, Buffers & Inducers
13.2.1.6. Other Upstream Products
13.2.2. Downstream Products
13.2.2.1. Filtration & Separation
13.2.2.2. Chromatography
13.2.2.3. Consumables & Accessories
13.2.2.4. Other Downstream Products
13.3.Market Value Forecast, by Application, 2016–2026
13.3.1. Antibiotics
13.3.2. Monoclonal Antibodies
13.3.3. Recombinant Proteins
13.3.4. Probiotics
13.3.5. Others
13.4.Market Value Forecast, by End-users, 2016–2026
13.4.1. Biopharmaceutical Companies
13.4.2. Contract Manufacturing Organizations
13.4.3. Contract Research Organizations
13.4.4. Academic Research Institutes
13.4.5. Food Industry
13.4.6. Others
13.5.Market Value Forecast, by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-Users
13.6.4. By Country
14. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Product, 2016–2026
14.2.1. Upstream Products
14.2.1.1. Bioreactors/Fermenters
14.2.1.2. Bioprocess Analyzers
14.2.1.3. Process Monitoring Systems
14.2.1.4. Media & Culture Preparation
14.2.1.5. Culture Media, Buffers & Inducers
14.2.1.6. Other Upstream Products
14.2.2. Downstream Products
14.2.2.1. Filtration & Separation
14.2.2.2. Chromatography
14.2.2.3. Consumables & Accessories
14.2.2.4. Other Downstream Products
14.3.Market Value Forecast, by Application, 2016–2026
14.3.1. Antibiotics
14.3.2. Monoclonal Antibodies
14.3.3. Recombinant Proteins
14.3.4. Probiotics
14.3.5. Others
14.4.Market Value Forecast, by End-users, 2016–2026
14.4.1. Biopharmaceutical Companies
14.4.2. Contract Manufacturing Organizations
14.4.3. Contract Research Organizations
14.4.4. Academic Research Institutes
14.4.5. Food Industry
14.4.6. Others
14.5.Market Value Forecast, by Country, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-users
14.6.4. By Country
15. Competition Landscape
15.1.Market Player – Competition Matrix (By Tier and Size of Companies)
15.2.Market Share Analysis, by Company (2016)
15.3.Market Footprint Analysis
15.3.1. By Region
15.3.2. By Product
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. GE Healthcare
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Company Financials
15.5.1.3. Growth Strategies
15.5.1.4. Recent Events
15.5.1.5. SWOT Analysis
15.5.2. Thermo Fisher Scientific Inc.
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Company Financials
15.5.2.3. Growth Strategies
15.5.2.4. Recent Events
15.5.2.5. SWOT Analysis
15.5.3. Danaher Corporation
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Company Financials
15.5.3.3. Growth Strategies
15.5.3.4. Recent Events
15.5.3.5. SWOT Analysis
15.5.4. Sartorius Stedim Biotech
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Company Financials
15.5.4.3. Growth Strategies
15.5.4.4. Recent Events
15.5.4.5. SWOT Analysis
15.5.5. Merck KGaA
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Company Financials
15.5.5.3. Growth Strategies
15.5.5.4. Recent Events
15.5.5.5. SWOT Analysis
15.5.6. Eppendorf AG
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Company Financials
15.5.6.3. Growth Strategies
15.5.6.4. Recent Events
15.5.6.5. SWOT Analysis
15.5.7. F. Hoffmann-La Roche Ltd.
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Company Financials
15.5.7.3. Growth Strategies
15.5.7.4. Recent Events
15.5.7.5. SWOT Analysis
15.5.8. Nova Biomedicals
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Growth Strategies
15.5.8.3. Recent Events
15.5.8.4. SWOT Analysis
15.5.9. Lonza
15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.9.2. Company Financials
15.5.9.3. Growth Strategies
15.5.9.4. Recent Events
15.5.9.5. SWOT Analysis
15.5.10. Becton, Dickinson and Company
15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.10.2. Company Financials
15.5.10.3. Growth Strategies
15.5.10.4. Recent Events
15.5.10.5. SWOT Analysis
Table 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
Table 03: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
Table 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 05: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) & Volume (Units) Forecast, by End-user, 2016–2026
Table 06: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 07: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 08: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Product, 2016–2026
Table 09: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Product, 2016–2026
Table 10: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 11: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 14: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Product, 2016–2026
Table 15: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Product, 2016–2026
Table 16: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 17: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 18: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 19: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 20: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
Table 21: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
Table 22: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 23: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 26: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
Table 27: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
Table 28: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 29: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 30: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 31: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 32: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
Table 33: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
Table 34: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 35: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 36: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026